Clinical Trial Update: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of alisertib for malignant rhabdoid tumors and atypical teratoid rhabdoid tumors, with the study currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Malignant Rhabdoid Tumor

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING